EUCLID, bringing experience to clinical trials

EUropean CLInical Trials Platform & Development (EUCLID) is a successful academic facility supporting the sponsor/investigator duo in the implementation of international and complex clinical trials, benefiting industrial and academic partners.

Our platform aims to strengthen its position as a centre of excellence for clinical trials to accelerate the development of evidence-based medicine at the national and international level.

Together, we are shaping the future of clinical research

EUCLID is an academic clinical research platform bringing together multidisciplinary, methodological and operational expertise to support the design and conduct of complex and international clinical trials. With a strong focus on infectious diseases and vaccinology, and supporting, the full clinical trial lifecycle, from study design to final dissemination, including in complex and ressource limited settings, EUCLID contributes to advancing high-impact clinical research globally.
Labelled platform:
Euclid is a consortium of:
Euclid is a consortium of:

Global expertise

Full range of clinical trial management activities from study design to reporting to Competent Authorities and dissemination, with the highest standards of quality management systems.

Methodology
From trial design to dissemination according to quality by design principles.
Support in project set-up
Support to develop protocols, obtain funding, seek ethical and regulatory approval.
Trial Management
Global coordination, site selection and monitoring, project management, GCP, ISO.
Data Management
eCRF, management of multi-dimension databases, data validation and cleaning.
Statistics
Conduct complexes statistical analyses.
Dissemination - Reporting
Support for grant applications, report writing and co-writing of publications.

EUCLID at a glance

28
High-profile projects
16
Public-Private Partnership Projects
10
European projects
+ 8000
Participants included in 21 different countries

EUCLID is currently managing 28 active international and / or complexe clinical research projects.

Latest news

Newsletter subscription

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.